Health Platform 160 HEALTH Surges Over 3% on Strong Hospital Partnership Growth

Stock News
06/03

160 HEALTH (SEHK: 02656) shares are trading higher, gaining more than 3% during the session. At the time of writing, the stock is up 2.5% to HK$13.94, with a trading volume of HK$122 million.

Key Developments Driving the Move

The company recently announced significant progress in its "160AI Hospital" operational partnership model from January 2025 through April 30, 2026. The total number of public medical institutions that have entered into operational cooperation with the group has now reached 120.

Within this total, 66 are top-tier Grade III, Class A hospitals, accounting for approximately 55% of the partnerships. The combined number of Grade III and above hospitals stands at 97, representing about 80.8% of the total cooperative institutions.

Significance of the Partnerships

This structure of partnered medical institutions demonstrates that the "160AI Hospital" operational model has gained strong recognition within China's high-end medical system. It has achieved deep penetration and scaled implementation among top-tier hospitals, continuously enhancing the company's brand influence and industry competitiveness.

Operational Service Performance

From January to April 2026, the online operational services provided by the group to its partner hospitals have shown significant effectiveness. These services have successfully helped hospitals expand their service offerings and improve operational efficiency.

As an example, the group provided online operational services for a leading Grade III, Class A hospital in Eastern China. The company charges a service commission of 10% of the Gross Merchandise Volume (GMV) generated. During the operational period, the group successfully assisted this hospital in achieving a breakthrough in online, non-insurance, out-of-pocket payment projects. The GMV for these services demonstrated a remarkable month-on-month compound growth rate of 155.7%.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10